Supplemental Table for: The impact of dupilumab on patch testing and the prevalence of co-morbid ACD in recalcitrant atopic dermatitis: a retrospective chart review
Published: 2 October 2019| Version 2 | DOI: 10.17632/2286p92mbj.2
Contributor:
Jodie Raffi
Description
Table A: Patient Characteristics and Comorbidities and Efficacy of Dupilumab